Rocky Mountain spotted fever is an acute febrile illness transmitted to man by ticks infected with Rickettsia rickettsii. Usually sudden in onset, it is characterized by chills, headache, and fever lasting 2 or more weeks. A characteristic rash appears on the extremities on about the 4th febrile day and spreads to the trunk. The exanthem and other anatomical manifestations result from focal areas of vasculitis and perivascular inflammation scattered throughout the body. Central nervous system (CNS) manifestations of delirium and coma as well as shock and renal failure occur in the severely ill. Serum antibodies to specific rickettsial antigens appear during the 2nd and 3rd weeks of illness. The tetracyclines are highly effective therapeutically.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aikawa, J. K. (1966). Rocky Mountain Spotted Fever. Springfield, IL: Thomas.
Wilson, L. B., & Chowning, W. M. (1904). Studies in pyroplasmosis hominis (“spotted fever" or “tick fever" of the Rocky Mountains). J Infect Dis, 1, 31–57.
Harden, V. A. (1990). Rocky Mountain Spotted Fever: History of a Twentieth-Century Disease. Baltimore: Johns Hopkins University Press.
Ricketts, H. T. (1906). The study of "Rocky Mountain spotted fever" (tick fever) by means of animal inoculations. J Am Med Assoc, 47, 1–10.
Ricketts, H. T. (1907). The role of the wood-tick (Dermacentor occidentalis) in Rocky Mountain spotted fever, and the susceptibility of local animals to this disease. J Am Med Assoc, 49, 24–27.
McCalla, L. P. (1908). Direct transmission from man to man of the Rocky Mountain spotted (tick) fever. Med Sentinel, 16, 87.
Wolbach, S. B. (1919). Studies on Rocky Mountain spotted fever. J Med Res, 41, 1–97.
Spencer, R. R., & Parker, R. R. (1930). Studies in Rocky Mountain Spotted Fever. Washington, DC: National Health Service, Hygienic Library Bull. No. 154, US Government Printing Office.
Cox, H. R. (1938). Use of yolk sac of developing chick embryo as medium for growing rickettsiae of Rocky Mountain spotted fever and typhus groups. Public Health Rep, 53, 2241–2247.
Rose, H. M., Duane, R. B., and Fischell, E. E. (1945). The treatment of spotted fever with para-aminobenzoic acid. J Am Med Assoc, 129, 1160–1163.
Woodward, T. E., & Jackson, E. B. (1965). Spotted fever rickettsiae. In J. Horsfall, F. L. & T. Tamm (Eds.), Viral and Rickettsial Infection of Man (4 ed., pp. 1095–1129). Philadelphia: Lippincott.
Pinkerton, H., & Maxcy, K. F. (1931). Pathological study of a case of endemic typhus in Virginia with demonstration of Rickettsia. Am J Pathol, 7, 95–103.
Dyer, R. E., Rumreich, A. S., & Badger, L. F. (1931). The typhus Rocky Mountain spotted fever group in the United States. J Am Med Assoc, 97, 589.
Pincoffs, M. C., & Shaw, C. C. (1933). The eastern type of Rocky Mountain spotted fever. Report of a case with demonstration of Rickettsia. Med Clin North Am, 16, 1097–1113.
Dumler, J. S. (1991). Fatal Rocky Mountain spotted fever in Maryland–1901. JAMA, 265(6), 718.
Helmick, C. G., Bernard, K. W., & D’Angelo, L. J. (1984). Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis, 150(4), 480–488.
Conlon, P. J., Procop, G. W., Fowler, V., Eloubeidi, M. A., Smith, S. R., & Sexton, D. J. (1996). Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med, 101(6), 621–626.
Pederson, C. E., Jr. (1977). Rocky Mountain spotted fever: A disease that must be recognized. J. Am. Med. Technol., 39, 190–198.
Sexton, D. J., Kanj, S. S., Wilson, K., Corey, G. R., Hegarty, B. C., Levy, M. G., et al. (1994). The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am J Trop Med Hyg, 50(1), 59–63.
Chapman, A. S., Bakken, J. S., Folk, S. M., Paddock, C. D., Bloch, K. C., Krusell, A., et al. (2006). Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis–United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep, 55(RR-4), 1–27.
Marrero, M., & Raoult, D. (1989). Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg, 40(2), 197–199.
Dumler, J. S., Gage, W. R., Pettis, G. L., Azad, A. F., & Kuhadja, F. P. (1990). Rapid immunoperoxidase demonstration of Rickettsia rickettsii in fixed cutaneous specimens from patients with Rocky Mountain spotted fever. Am J Clin Pathol, 93(3), 410–414.
Woodward, T. E., Pedersen, C. E., Jr., Oster, C. N., Bagley, L. R., Romberger, J., & Snyder, M. J. (1976). Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis, 134(3), 297–301.
Walker, D. H., Cain, B. G., & Olmstead, P. M. (1978). Laboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia in Cutaneous lesions. Am J Clin Pathol, 69(6), 619–623.
Walker, D. H., & Cain, B. G. (1978). A method for specific diagnosis of Rocky Mountain spotted fever on fixed, paraffin-embedded tissue by immunofluorescence. J Infect Dis, 137(2), 206–209.
Paddock, C. D., Sumner, J. W., Comer, J. A., Zaki, S. R., Goldsmith, C. S., Goddard, J., et al. (2004). Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis, 38(6), 805–811.
Smadel, J. E., & Jackson, E. B. (1964). Rickettsial infections. In L. E. H. & S. N. J. (Eds.), Diagnostic Procedures for Viral and Rickettsial Diseases (3rd ed., pp. 743–771). New York: American Public Health Association.
Kelly, P. J., Matthewman, L. A., Mahan, S. M., Semu, S., Peter, T., Mason, P. R., et al. (1994). Serological evidence for antigenic relationships between Ehrlichia canis and Cowdria ruminantium. Res Vet Sci, 56(2), 170–174.
Dumler, J. S., & Walker, D. H. (1994). Diagnostic tests for Rocky Mountain spotted fever and other rickettsial diseases. Dermatol Clin, 12(1), 25–36.
Clements, M. L., Dumler, J. S., Fiset, P., Wisseman, C. L., Jr., Snyder, M. J., & Levine, M. M. (1983). Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test. J Infect Dis, 148(5), 876–880.
Philip, R. N., Casper, E. A., Ormsbee, R. A., Peacock, M. G., & Burgdorfer, W. (1976). Microimmunofluorescence test for the serological study of Rocky Mountain spotted fever and typhus. J Clin Microbiol, 3(1), 51–61.
Hechemy, K. E., Michaelson, E. E., Anacker, R. L., Zdeb, M., Sasowski, S. J., Kleeman, K. T., et al. (1983). Evaluation of latex-Rickettsia rickettsii test for Rocky Mountain spotted fever in 11 laboratories. J Clin Microbiol, 18(4), 938–946.
Radulovic, S., Speed, R., Feng, H. M., Taylor, C., & Walker, D. H. (1993). EIA with species-specific monoclonal antibodies: a novel seroepidemiologic tool for determination of the etiologic agent of spotted fever rickettsiosis. J Infect Dis, 168(5), 1292–1295.
Fuller, H. S. (1959). Biologic properties of pathogenic rickettsiae. Arch Inst Pasteur Tunis, 36, 311–338.
Price, W. H. (1953). The epidemiology of Rocky Mountain spotted fever: The characterization of strain virulence of Rickettsia rickettsii. Am J Hyg, 58, 248–268.
Kaplowitz, L. G., Lange, J. V., Fischer, J. J., & Walker, D. H. (1983). Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. Arch Intern Med, 143(6), 1149–1151.
Hackstadt, T., Messer, R., Cieplak, W., & Peacock, M. G. (1992). Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing. Infect Immun, 60(1), 159–165.
Li, H., & Walker, D. H. (1998). rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog, 24(5), 289–298.
Uchiyama, T. (2003). Adherence to and invasion of Vero cells by recombinant Escherichia coli expressing the outer membrane protein rOmpB of Rickettsia japonica. Ann N Y Acad Sci, 990, 585–590.
Sumner, J. W., Sims, K. G., Jones, D. C., & Anderson, B. E. (1995). Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein. Vaccine, 13(1), 29–35.
Crocquet-Valdes, P. A., Diaz-Montero, C. M., Feng, H. M., Li, H., Barrett, A. D., & Walker, D. H. (2001). Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine, 20(5–6), 979–988.
Martinez, J. J., Seveau, S., Veiga, E., Matsuyama, S., & Cossart, P. (2005). Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell, 123(6), 1013–1023.
Heinzen, R. A., Hayes, S. F., Peacock, M. G., & Hackstadt, T. (1993). Directional actin polymerization associated with spotted fever group Rickettsia infection of Vero cells. Infect Immun, 61(5), 1926–1935.
Gouin, E., Egile, C., Dehoux, P., Villiers, V., Adams, J., Gertler, F., et al. (2004). The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature, 427(6973), 457–461.
Martinez, J. J., & Cossart, P. (2004). Early signaling events involved in the entry of Rickettsia conorii into mammalian cells. J Cell Sci, 117 (Pt 21), 5097–5106.
Hattwick, M. A., O’Brien, R. J., & Hanson, B. F. (1976). Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med, 84(6), 732–739.
Marshall, G. S., Stout, G. G., Jacobs, R. F., Schutze, G. E., Paxton, H., Buckingham, S. C., et al. (2003). Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med, 157(5), 443–448.
Galvao, M. A., Calic, S. B., Chamone, C. B., Mafra, S. C., Cesarino Filho, G., Olano, J. P., et al. (2003). Spotted fever rickettsiosis in Coronel Fabriciano, Minas Gerais State. Rev Soc Bras Med Trop, 36(4), 479–481.
Galvao, M. A., Dumler, J. S., Mafra, C. L., Calic, S. B., Chamone, C. B., Cesarino Filho, G., et al. (2003). Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis, 9(11), 1402–1405.
Parola, P., Davoust, B., & Raoult, D. (2005). Tick- and flea-borne rickettsial emerging zoonoses. Vet Res, 36(3), 469–492.
Cox, H. R. (1959). The spotted fever group. In M. Rivers & F. L. Horsfall (Eds.), Viral and Rickettsial Diseases of Man (3rd ed., pp. 828–868). Philadelphia: Lippincott.
Kohls, G. M. (1948). Vectors of rickettsial diseases. In F. R. Moulton (Ed.), Rickettsial Diseases of Man (pp. 83–96). Washington, DC: American Association for the Advancement of Science.
Demma, L. J., Traeger, M. S., Nicholson, W. L., Paddock, C. D., Blau, D. M., Eremeeva, M. E., et al. (2005). Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med, 353(6), 587–594.
CDC. (2004). Fatal cases of Rocky Mountain spotted fever in family clusters–three states, 2003. MMWR Morb Mortal Wkly Rep, 53(19), 407–410.
Jones, T. F., Craig, A. S., Paddock, C. D., McKechnie, D. B., Childs, J. E., Zaki, S. R., et al. (1999). Family cluster of Rocky Mountain spotted fever. Clin Infect Dis, 28(4), 853–859.
DuPont, H. L., Hornick, R. B., Dawkins, A. T., Heiner, G. G., Fabrikant, I. B., Wisseman, C. L., Jr., et al. (1973). Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis, 128(3), 340–344.
Woodward, T. E. (1959). Rickettsial diseases in the United States. Med Clin North Am, 43, 1507–1535.
Ley, H. L., Jr., Diercks, F. H., Paterson, P. Y., & al., e. (1952). Immunization against scrub typhus. IV. Living Karp vaccine and chemoprophylaxis in volunteers. Am J Hyg, 56, 303–312.
Tigertt, W. D. (1959). Studies on Q Fever in Man. Paper presented at the Symposium of Q Fever, Washington, DC.
Walker, D. H., Firth, W. T., Ballard, J. G., & Hegarty, B. C. (1983). Role of phospholipase-associated penetration mechanism in cell injury by Rickettsia rickettsii. Infect Immun, 40(2), 840–842.
Walker, T. S. (1984). Rickettsial interactions with human endothelial cells in vitro: adherence and entry. Infect Immun, 44(2), 205–210.
Renesto, P., Dehoux, P., Gouin, E., Touqui, L., Cossart, P., & Raoult, D. (2003). Identification and characterization of a phospholipase D-superfamily gene in rickettsiae. J. Infect. Dis., 188(9), 1276–1283.
Whitworth, T., Popov, V. L., Yu, X. J., Walker, D. H., & Bouyer, D. H. (2005). Expression of the Rickettsia prowazekii pld or tlyC gene in Salmonella enterica serovar Typhimurium mediates phagosomal escape. Infect Immun, 73(10), 6668–6673.
Silverman, D. J., & Santucci, L. A. (1988). Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever. Infect Immun, 56(12), 3110–3115.
Rydkina, E., Sahni, S. K., Santucci, L. A., Turpin, L. C., Baggs, R. B., & Silverman, D. J. (2004). Selective modulation of antioxidant enzyme activities in host tissues during Rickettsia conorii infection. Microb Pathog, 36(6), 293–301.
Sahni, S. K., Rydkina, E., Sahni, A., Joshi, S. G., & Silverman, D. J. (2005). Potential roles for regulatory oxygenases in rickettsial pathogenesis. Ann N Y Acad Sci, 1063, 207–214.
Feng, H. M., & Walker, D. H. (1993). Interferon-gamma and tumor necrosis factor-alpha exert their antirickettsial effect via induction of synthesis of nitric oxide. Am J Pathol, 143(4), 1016–1023.
Valbuena, G., Feng, H. M., & Walker, D. H. (2002). Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect, 4(6), 625–633.
Sporn, L. A., Lawrence, S. O., Silverman, D. J., & Marder, V. J. (1993). E-selectin-dependent neutrophil adhesion to Rickettsia rickettsii-infected endothelial cells. Blood, 81(9), 2406–2412.
Feng, H. M., Wen, J., & Walker, D. H. (1993). Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis. Am J Pathol, 142(5), 1471–1482.
Billings, A. N., Feng, H. M., Olano, J. P., & Walker, D. H. (2001). Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. Am J Trop Med Hyg, 65(1), 52–56.
Clements, M. L., Wisseman, C. L., Jr., Woodward, T. E., Fiset, P., Dumler, J. S., McNamee, W., et al. (1983). Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J Infect Dis, 148(5), 922–930.
Dumler, J. S., Wisseman, C. L., Jr., Fiset, P., & Clements, M. L. (1992). Cell-mediated immune responses of adults to vaccination, challenge with Rickettsia rickettsii, or both. Am J Trop Med Hyg, 46(2), 105–115.
O’Reilly, M., Paddock, C., Elchos, B., Goddard, J., Childs, J., & Currie, M. (2003). Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad Sci, 990, 295–301.
Watt, G., & Strickman, D. (1994). Life-threatening scrub typhus in a traveler returning from Thailand. Clin Infect Dis, 18(4), 624–626.
McDonald, J. C., MacLean, J. D., & McDade, J. E. (1988). Imported rickettsial disease: clinical and epidemiologic features. Am J Med, 85(6), 799–805.
Jensenius, M., Fournier, P. E., & Raoult, D. (2004). Rickettsioses and the international traveler. Clin Infect Dis, 39(10), 1493–1499.
Needham, G. R. (1985). Evaluation of five popular methods for tick removal. Pediatrics, 75(6), 997–1002.
Kenyon, R. H., Williams, R. G., Oster, C. N., & Pedersen, C. E., Jr. (1978). Prophylactic treatment of Rocky Mountain spotted fever. J. Clin. Microbiol., 8(1), 102–104.
Holman, R. C., Paddock, C. D., Curns, A. T., Krebs, J. W., McQuiston, J. H., & Childs, J. E. (2001). Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis, 184(11), 1437–1444.
Dalton, M. J., Clarke, M. J., Holman, R. C., Krebs, J. W., Fishbein, D. B., Olson, J. G., et al. (1995). National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg, 52(5), 405–413.
Spencer, R. R., & Parker, R. R. (1923). Rocky Mountain spotted fever: Infectivity of fasting and recently fed ticks. Public Health Rep, 38, 33.
Spencer, R. R., & Parker, R. R. (1925). Studies on Rocky Mountain spotted fever: Vaccination of monkeys and man. Public Health Rep., 40, 2159.
Parker, R. R. (1941). Rocky Mountain spotted fever: Results of fifteen years of prophylactic vaccination. Am. J. Trop. Med. Hyg., 21, 369.
Smadel, J. E. (1960). Rocky Mountain spotted fever vaccine. Paper presented at the Symposium on the Spotted Fever Group, Med. Sci. Publ. No. 7 WRAIR 55–61, Washington, DC.
McDonald, G. A., Anacker, R. L., Mann, R. E., & Milch, L. J. (1988). Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii. J Infect Dis, 158(1), 228–231.
Zhang, J. Z., Hao, J. F., Walker, D. H., & Yu, X. J. (2006). A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir. Vaccine, 24(13), 2317–2323.
Suggested Reading
Dumler, J. S. & Walker, D. H. (2005). Rocky Mountain spotted fever–changing ecology and persisting virulence. N Engl J Med, 353(6), 551–553.
Paddock, C. D., Holman, R. C., Krebs, J. W., & Childs, J. E. (2002). Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg, 67(4), 349–354.
Paddock, C. D., Greer, P. W., Ferebee, T. L., Singleton, J. Jr., McKechnie, D. B., Treadwell, T. A., Krebs, J. W., Clarke, M. J., Holman, R. C., Olson, J. G., Childs, J. E., & Zaki, S. R. (1999). Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis, 179(6), 1469–1476.
Razzaq, S. & Schutze, G.E. (2005). Rocky Mountain spotted fever: a physician’s challenge. Pediatr Rev Apr, 26(4), 125–30.
Walker, D. H. (2002). Rickettsia rickettsii: as virulent as ever. Am J Trop Med Hyg, 66(5), 448–449.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Milstone, A., Dumler, J.S. (2009). Rocky Mountain Spotted Fever. In: Brachman, P., Abrutyn, E. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09843-2_31
Download citation
DOI: https://doi.org/10.1007/978-0-387-09843-2_31
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09842-5
Online ISBN: 978-0-387-09843-2
eBook Packages: MedicineMedicine (R0)